Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. SNOW
2. AVGO
3. RARE
4. HPE
5. FIVE
6. VRTS
7. SPY
8. NTAP
9. NTSK
10. OLLI

Go back to Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat)
Merck & Co. (NYSE: MRK) Delayed: 150.95 -0.69 (0.46%)
Previous Close $151.64    52 Week High $65.46 
Open $152.54    52 Week Low $47.97 
Day High $152.80    P/E 102.69 
Day Low $150.86    EPS $1.47 
Volume 215,203